Nov 26, 2018 5:26 pm EST Eyenovia Initiates Phase III MicroStat Program for Pharmacologic Mydriasis: Enrolls First Patient in MIST-1 Study
Nov 13, 2018 7:30 am EST Eyenovia Announces FDA Acceptance of MicroStat IND Application for Mydriasis
Nov 1, 2018 8:30 am EDT Eyenovia Announces Conference Call and Webcast for Third Quarter 2018 Financial Results
Oct 23, 2018 9:00 am EDT Eyenovia to Present at the Ophthalmology Innovation Summit at the American Academy of Ophthalmology 2018
Aug 21, 2018 7:30 am EDT Eyenovia to Present at the 20th Annual H.C. Wainwright Global Investment Conference
Aug 13, 2018 8:30 am EDT Eyenovia’s EYN PG21 Trial Evaluating High-Precision Microdose of Latanoprost Demonstrates Robust Intraocular Pressure Lowering and Patient Usability